Literature DB >> 33623619

Ethical issues in the COVID-19 pandemic control preparedness in a developing economy.

Ayodele Jegede1,2, IkeOluwapo Ajayi2,3, Simisola Akintola2,4, Catherine Falade5, Isaac Oluwafemi Dipeolu2,6, Simeon Cadmus2,7, Ajala Aderemi2,8, Abayomi Olaifa2,9, Olufemi Olatoye2,5, Odunayo Akinyemi2,3.   

Abstract

Adequate preparation for highly pathogenic infectious disease pandemic can reduce the incidence, prevalence and burden of diseases like COVID-19 pandemic. An antidote to the spread of the disease is adequate preparation for its control since there is no proven curative measure yet. Effective management of identified cases, social distancing, contact tracing and provision of basic infrastructure to facilitate compliance with preventive measures, testing are proven management strategies. Although these measures seem to be the best options presently, it is important to pay attention to ethical issues arising from the implementation process to ensure best practice. While disease epidemic is not alien to human societies, lessons from previous outbreaks are vital for addressing future outbreaks. For effective control of this pandemic, there should be a clear definition of social distancing in terms of distance and space in line with the WHO definition, adequate provision of basic amenities, screening and testing with specific criteria for selecting those to be screened. Also, there should be a free testing procedure, access to treatment opportunities for those who test positive, ethical free contact tracing practice, respect for the autonomy of those to be tested, and global best practice of open science, open data and data sharing practices. In conclusion, a framework/guideline for epidemic/pandemic ethics guidance should be developed while an ethical sensitive communication manual should be prepared for public engagement on epidemic and pandemic. © Ayodele Jegede et al.

Entities:  

Keywords:  Pandemic preparedness; disease control; ethics

Year:  2020        PMID: 33623619      PMCID: PMC7875799          DOI: 10.11604/pamj.supp.2020.35.23121

Source DB:  PubMed          Journal:  Pan Afr Med J


  4 in total

1.  Ethical Considerations for Movement Mapping to Identify Disease Transmission Hotspots.

Authors:  Bouke C de Jong; Badou M Gaye; Jeroen Luyten; Bart van Buitenen; Emmanuel André; Conor J Meehan; Cian O'Siochain; Kristyna Tomsu; Jérôme Urbain; Koen Peeters Grietens; Maureen Njue; Wim Pinxten; Florian Gehre; Ousman Nyan; Anne Buvé; Anna Roca; Raffaella Ravinetto; Martin Antonio
Journal:  Emerg Infect Dis       Date:  2019-07       Impact factor: 6.883

2.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

3.  Outbreak of lassa fever in Nigeria: measures for prevention and control.

Authors:  Kehinde Charles Mofolorunsho
Journal:  Pan Afr Med J       Date:  2016-04-20

Review 4.  Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.

Authors:  Sasmita Poudel Adhikari; Sha Meng; Yu-Ju Wu; Yu-Ping Mao; Rui-Xue Ye; Qing-Zhi Wang; Chang Sun; Sean Sylvia; Scott Rozelle; Hein Raat; Huan Zhou
Journal:  Infect Dis Poverty       Date:  2020-03-17       Impact factor: 4.520

  4 in total
  1 in total

Review 1.  Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review.

Authors:  Mark Embrett; S Meaghan Sim; Hilary A T Caldwell; Leah Boulos; Ziwa Yu; Gina Agarwal; Rhiannon Cooper; Allyson J Gallant Aj; Iwona A Bielska; Jawad Chishtie; Kathryn Stone; Janet Curran; Andrea Tricco
Journal:  BMC Public Health       Date:  2022-04-14       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.